Showing all 11 results

  • Placeholder
    In Stock

    Nitrofurantoin Tablets

    Free

    Nitrofurantoin tablet is an antibiotic specifically used to treat and prevent urinary tract infections (UTIs), such as cystitis. It works by damaging the DNA of bacteria in the urinary tract.

  • Placeholder
    In Stock

    Nitrofurantoin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Dual-Release Capsule or Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the nitrofuran compounds.

    Active IngredientStrengthPrimary Clinical Function
    Nitrofurantoin (Macrocrystals) USP/Ph.Eur.50 mgProphylactic / Pediatric Standard: Base therapeutic unit for long-term prevention of recurrent UTIs and pediatric dosing.
    Nitrofurantoin (Macrocrystals 25mg + Monohydrate 75mg) USP100 mgGlobal Acute UTI Standard: Premium dual-release adult maintenance dose for the rapid eradication of acute uncomplicated cystitis.
    ExcipientsCarbomer 934P / Povidone K30 / Sugar Spheres / Talc / Magnesium Stearate / Titanium DioxideHydrophilic Polymer Matrix / Binder / Core Substrate / Glidant (Engineered specifically to form a viscous gel upon swallowing, pacing the gastric release perfectly to prevent nausea while ensuring maximum urinary concentration)

    *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict 5-to-7 day acute urology dispensing regimens).

  • Placeholder
    In Stock

    Oxybutynin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE desiccant bottles to ensure the absolute chemical stability of the controlled-release hydrogel network.

    Active IngredientStrengthPrimary Clinical Function
    Oxybutynin Chloride USP/Ph.Eur.5 mg (ER)Initiation Standard: Base once-daily titration unit for the gradual introduction of antimuscarinic therapy.
    Oxybutynin Chloride USP/Ph.Eur.10 mg / 15 mg (ER)Global Clinical Standard: Advanced maintenance doses for severe, refractory Overactive Bladder and neurogenic detrusor overactivity.
    ExcipientsHypromellose (HPMC) / Lactose Anhydrous / Macrogol (PEG) / Magnesium Stearate / Titanium DioxideHydrophilic Polymer Matrix / Diluent / Plasticizer / Premium Film-Coating (Engineered specifically to form a highly viscous external gel barrier upon swallowing, controlling the exact 24-hour drug diffusion rate)

    *Pack Sizes: Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 30-day chronic urology dispensing regimens).

  • Placeholder
    In Stock

    Phenazopyridine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant PVC/PVDC or Alu-PVC blister strips to ensure the stability of the active dye compound.

    Active IngredientStrengthPrimary Clinical Function
    Phenazopyridine Hydrochloride USP/Ph.Eur.100 mgStandard OTC/Initiation dose for mild-to-moderate urinary tract discomfort.
    Phenazopyridine Hydrochloride USP/Ph.Eur.200 mgGlobal Prescription Standard: Maximum adult dose for severe dysuria and post-operative catheter trauma.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Magnesium StearateDiluent / Superdisintegrant (Engineered for rapid gastric dissolution and swift renal clearance)
  • Placeholder
    In Stock

    Phenazopyridine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant high-density PVC/PVDC or Alu-PVC blister strips to ensure absolute chemical stability and prevent dye leakage.

    Active IngredientStrengthPrimary Clinical Function
    Phenazopyridine HCl USP/Ph.Eur.100 mgOTC Standard: Base therapeutic unit for mild to moderate UTI symptom relief.
    Phenazopyridine HCl USP/Ph.Eur.200 mgPrescription Standard: Maximum adult dose for severe, acute dysuria and post-surgical trauma.
    ExcipientsMicrocrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Heavy Carnauba Wax CoatingDiluent / Superdisintegrant / Binder / Lubricant / Premium Film-Coating (Engineered specifically to seal the intense red dye inside the tablet, preventing it from staining the patient’s hands or mouth upon swallowing)

    *Pack Sizes: 10×10 Blisters (Optimized specifically for high-turnover acute dispensing and short-term 2-day urology protocols).

  • Placeholder
    In Stock

    Prulifloxacin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the ester prodrug.

    Active IngredientStrengthPrimary Clinical Function
    Prulifloxacin INN/Ph.Eur.600 mgGlobal Clinical Standard: Maximum adult daily dose for the rapid eradication of susceptible UTI and RTI pathogens.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Povidone / Magnesium Stearate / HypromelloseDiluent / Superdisintegrant / Binder / Lubricant / Premium Film-Coating (Engineered for immediate gastric dissolution and synchronized prodrug absorption)

    *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for standard 3-to-10 day acute urology and respiratory infection dispensing regimens).

  • Placeholder
    In Stock

    Silodosin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Silodosin INN/Ph.Eur.8 mgGlobal Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH.
    ExcipientsMannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium DioxideDiluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability)

    *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).

  • Placeholder
    In Stock

    Solifenacin Succinate Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or High-Density Alu-PVC blister strips to ensure the absolute stability of the low-dose API.

    Active IngredientStrengthPrimary Clinical Function
    Solifenacin Succinate USP/Ph.Eur.5 mgGlobal Standard: Starting and standard maintenance dose for Overactive Bladder; required maximum dose for patients with hepatic/renal impairment.
    Solifenacin Succinate USP/Ph.Eur.10 mgHigh-Dose Therapy: Maximum adult dose for severe, refractory urinary urgency and frequency.
    ExcipientsLactose Monohydrate / Maize Starch / Hypromellose / Magnesium Stearate / MacrogolDiluent / Binder / Premium Film-Coating (Engineered for immediate gastric dissolution and light protection)
  • Placeholder
    In Stock

    Tamsulosin & Dutasteride Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.

    Active IngredientStrengthPrimary Clinical Function
    Tamsulosin Hydrochloride USP/Ph.Eur.0.4 mg (Modified-Release)Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief.
    Dutasteride USP/Ph.Eur.0.5 mgDual 5-alpha-reductase inhibition for profound DHT suppression and prostate volume reduction.
    ExcipientsHypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Microcrystalline Cellulose / Magnesium StearateSR Polymer matrix for Tamsulosin / Antioxidant stabilizer for solid-state Dutasteride (Engineered for strict segregation)
  • Placeholder
    In Stock

    Tamsulosin & Finasteride Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.

    Active IngredientStrengthPrimary Clinical Function
    Tamsulosin Hydrochloride USP/Ph.Eur.0.4 mg (Modified-Release)Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief.
    Finasteride USP/Ph.Eur.5 mgTargeted Type II 5-alpha-reductase inhibition for profound DHT suppression and prostate shrinkage.
    ExcipientsHypromellose (HPMC) / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium StearateSR Polymer matrix for Tamsulosin / Diluent for Finasteride (Engineered for strict kinetic segregation)
  • Placeholder
    In Stock

    Tamsulosin Tablets 

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Gel-Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the hygroscopic polymers.

    Active IngredientStrengthPrimary Clinical Use
    Tamsulosin Hydrochloride USP/Ph.Eur.0.4 mg (Modified-Release Tablet)Premium Global Standard: Target once-daily, food-independent adult dose for BPH.
    ExcipientsMacrogol (Polyethylene Glycol) / Magnesium Stearate / Hypromellose / Iron OxideAdvanced Non-Ionic Gel Matrix / Lubricant / Film Coat (Engineered for strict 24-hour continuous diffusion)